FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...

New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.

Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...

For Americans, here’s what medical history and new research say about the bonuses of vaccines beyond preventing the diseases ...

A new study review says increasing water intake could aid weight loss, help prevent kidney stones, and more. Here’s what to know.

COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.